ArticleProceedings of the National Academy of Sciences of the United States of America2021

Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.